- Home
- PRTA vs LFCR Comparison
PRTA vs LFCR Comparison
Compare PRTA & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTA
- LFCR
- Stock Information
- Founded
- PRTA 2012
- LFCR 1986
- Country
- PRTA Ireland
- LFCR United States
- Employees
- PRTA N/A
- LFCR N/A
- Industry
- PRTA Biotechnology: Pharmaceutical Preparations
- LFCR Biotechnology: Pharmaceutical Preparations
- Sector
- PRTA Health Care
- LFCR Health Care
- Exchange
- PRTA Nasdaq
- LFCR Nasdaq
- Market Cap
- PRTA 346.4M
- LFCR 308.8M
- IPO Year
- PRTA N/A
- LFCR N/A
- Fundamental
- Price
- PRTA $6.29
- LFCR $7.49
- Analyst Decision
- PRTA Buy
- LFCR Buy
- Analyst Count
- PRTA 9
- LFCR 4
- Target Price
- PRTA $27.67
- LFCR $8.00
- AVG Volume (30 Days)
- PRTA 1.3M
- LFCR 227.7K
- Earning Date
- PRTA 08-07-2025
- LFCR 08-25-2025
- Dividend Yield
- PRTA N/A
- LFCR N/A
- EPS Growth
- PRTA N/A
- LFCR N/A
- EPS
- PRTA N/A
- LFCR N/A
- Revenue
- PRTA $137,935,000.00
- LFCR $130,309,000.00
- Revenue This Year
- PRTA N/A
- LFCR $1.64
- Revenue Next Year
- PRTA $122.02
- LFCR $2.91
- P/E Ratio
- PRTA N/A
- LFCR N/A
- Revenue Growth
- PRTA 54.55
- LFCR 7.23
- 52 Week Low
- PRTA $4.32
- LFCR $3.68
- 52 Week High
- PRTA $25.42
- LFCR $8.85
- Technical
- Relative Strength Index (RSI)
- PRTA 56.80
- LFCR 45.48
- Support Level
- PRTA $6.16
- LFCR $8.10
- Resistance Level
- PRTA $6.60
- LFCR $8.85
- Average True Range (ATR)
- PRTA 0.27
- LFCR 0.38
- MACD
- PRTA 0.04
- LFCR -0.12
- Stochastic Oscillator
- PRTA 67.90
- LFCR 0.73
About PRTA Prothena Corporation plc
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.